» Articles » PMID: 36820651

New Insights on Tuberculosis Transmission Dynamics and Drug Susceptibility Profiles Among the Prison Population in Southern Brazil Based on Whole-genome Sequencing

Abstract

Background: The rate of tuberculosis (TB) infection among the prison population (PP) in Brazil is 28 times higher than that in the general population, and prison environment favors the spread of TB.

Objective: To describe TB transmission dynamics and drug resistance profiles in PP using whole-genome sequencing (WGS).

Methods: This was a retrospective study of Mycobacterium tuberculosis cultivated from people incarcerated in 55 prisons between 2016 and 2019; only one isolate per prisoner was included. Information about movement from one prison to another was tracked. Clinical information was collected, and WGS was performed on isolates obtained at the time of TB diagnosis.

Results: Among 134 prisoners included in the study, we detected 16 clusters with a total of 58 (43%) cases of M. tuberculosis. Clusters ranged from two to seven isolates with five or fewer single nucleotide polymorphism (SNP) differences, suggesting a recent transmission. Six (4.4%) isolates were resistant to at least one anti-TB drug. Two of these clustered together and showed resistance to rifampicin, isoniazid, and fluoroquinolones, with 100% concordance between WGS and phenotypic drug-susceptibility testing. Prisoners with clustered isolates had a high amount of movement between prisons (two to eight moves) during the study period.

Conclusions: WGS demonstrated the recent transmission of TB within prisons in Brazil. The high movement among prisoners seems to be related to the transmission of the same M. tuberculosis strain within the prison system. Screening for TB before and after the movement of prisoners using rapid molecular tests could play a role in reducing transmission.

Citing Articles

Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines.

Wang L, Lim D, Phelan J, Reyes L, Palparan A, Sanchez M Sci Rep. 2024; 14(1):19602.

PMID: 39179783 PMC: 11344074. DOI: 10.1038/s41598-024-70471-x.


Insights into SARS-CoV-2 Surveillance among Prison Populations in Mato Grosso do Sul, Brazil, in 2022.

Ferreira da Silva L, Alcantara L, Fonseca V, Frias D, Zardin M, Lichs G Viruses. 2024; 16(7).

PMID: 39066305 PMC: 11281713. DOI: 10.3390/v16071143.


Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine.

Dohal M, Porvaznik I, Solovic I, Mokry J Front Microbiol. 2023; 14:1225438.

PMID: 37860132 PMC: 10582268. DOI: 10.3389/fmicb.2023.1225438.

References
1.
Warren J, Grandjean L, Moore D, Lithgow A, Coronel J, Sheen P . Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis. BMC Med. 2018; 16(1):122. PMC: 6091024. DOI: 10.1186/s12916-018-1111-x. View

2.
Gygli S, Loiseau C, Jugheli L, Adamia N, Trauner A, Reinhard M . Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis. Nat Med. 2021; 27(7):1171-1177. PMC: 9400913. DOI: 10.1038/s41591-021-01358-x. View

3.
Walker T, Ip C, Harrell R, Evans J, Kapatai G, Dedicoat M . Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis. 2012; 13(2):137-46. PMC: 3556524. DOI: 10.1016/S1473-3099(12)70277-3. View

4.
Seraphin M, Didelot X, Nolan D, May J, Khan M, Murray E . Genomic Investigation of a Outbreak Involving Prison and Community Cases in Florida, United States. Am J Trop Med Hyg. 2018; 99(4):867-874. PMC: 6159577. DOI: 10.4269/ajtmh.17-0700. View

5.
Droznin M, Johnson A, Johnson A . Multidrug resistant tuberculosis in prisons located in former Soviet countries: A systematic review. PLoS One. 2017; 12(3):e0174373. PMC: 5363920. DOI: 10.1371/journal.pone.0174373. View